applications of statistics on banking and pharmaceutical companies
TRANSCRIPT
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
1/34
DDeeppaarrttmmeennttooffFFiinnaannccee
FFaaccuullttyy ooffBBuussiinneessss SSttuuddiieess
UU
nn
iivv
ee
rr
ss
iittyy
oo
ff
DD
hh
aa
kk
aa
TTiittllee oofftthhee SSttuuddyy::
AApppplliiccaattiioonnss ooffSSttaattiissttiiccss
OOnn
BBaannkkiinngg aanndd PPhhaarrmmaacceeuuttiiccaall
CCoommppaanniieess
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
2/34
Course Title: Business Statistics IICourse Code:F-207
S U B M I T T E D T O
Ms. Nusrat Khan
Lecture
Department of Finance
University of Dhaka
S U B M I T T E D B Y
Section A
BBA 16th Batch
Department of Finance
University of Dhaka
Date of Submission:November 2, 2011
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
3/34
ABOUT US
SLNO.
NAME ID1 Md. Rabin Islam 16-0132 Mohammad Junaid Shawon 16-0173 Md. Zahidul Islam 16-0514 Md. Rashed Karim 16-1255 Rashid Muntasir 16-1656 Md. Zahirul Islam Khan 16-1717 Md. Sanowar Hossain 16-1758 Ariful Hossain 16-2629 Md. Mahbubur Rahman Khan 16-263
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
4/34
LE TTE R OF TR AN S M I TTAL
November 2, 2011
Ms. Nusrat KhanLecturerDepartment of FinanceUniversity of Dhaka
Dear Madam,
It is our satisfaction to submit this report, which you assigned us. The topic of our reportis Applications of Statistics On Banking and Pharmaceutical Companies as a part of therequirements under the Course of Business Statistics II. Working on this report was agreat opportunity for us to acquire knowledge about many applications of descriptive &inferential statistics.
We are thankful to you, as you allowed us to perform the study and to submit the report.We hope that the report will meet the standard and will serve its purpose.
Sincerely Yours,
Md. Zahidul IslamOn behalf of the group
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
5/34
ACKN OW LE D GE M E N T
For the completion of this study we cant deserve all praise. There were a lot of people
who helped us by providing valuable information, advice and guidance for the
completion of this Report in the scheduled time.
Course Report is an essential part of BBA program as one can gather practical knowledge
within the short period of time by observing and doing the works of chosen
organizations. In this regard our Report has been arranged.
At first we like to pay our heartiest thanks to ALMIGHTY, for helping us to do all the
works with perfection. Having prepared this report, we would like to give our thanks to
the Department of Finance and all the faculties of the department as they have given us
the opportunity to be a part of the BBA Program. We also thank them for preparing such
a curriculum as a part of which we have been able to accomplish this report.
We would like to pay our gratitude to our supervising Course teacher Ms. Nusrat Khan
who instructed us in the right way and gave us proper guidelines for preparing this
Report.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
6/34
EXECUTIVE SUMMARY
We have prepared this report on the study of Applications of Statistics On Bankingand Pharmaceutical Companies in which we have discussed the applications of somestatistical tools in business and commerce. These tools are-
Time series & Forecasting
Multiple regression & correlation analysis
The report starts with introducing the origin, objectives & methodology of the report at
the first part. The origin section describes the background of the preparation of this
report, while the objectives section explains the objectives of the preparation of this
report. The methodology section deals with the means of preparation of this report and
the processes that we have followed. Then the report describes various important topics
of time series analysis & multiple regression & correlation analysis in the theoretical
knowledge at the second part.
Thereafter at the third part there are Company profiles of four selected companies from
two different industries. Then we have shown the application of some statistical tools on
these companies.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
7/34
INTRODUCTION
Origin of the Report:
This Report is generated under the academic supervision of Ms. Nusrat Khan, Lecturer,
Department of Finance, University of Dhaka. The report is a prerequisite for the
completion of the course Business Statistics II under BBA Program. Each student has
to work on a report within a predetermined group over the period of this Program. The
assigned topic for our Report is Applications of Statistics On Banking and
Pharmaceutical Companies
Objectives of the Report:
The objective of preparing this report is to fulfill the requirement of the course Business
Statistics II through gaining the theoretical knowledge about various important topics
of business statistics and viewing the applications & tabular presentation of those topics.
Methodology of the Report:
The report in this study is basically an analytical one. Here, both the primary and the
secondary data have been used. The primary data has been collected from lectures given
on this topic in the classroom. The secondary sources of data are our textbook, reference
book, annual reports of the selected company & different websites. We used the
sophisticated data editorSPSS for our analyses.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
8/34
TH E OR E TI CAL KN OW LE D GE
Time Series & Forecasting:
A time series is a collection of data recorded over a period of time; weekly, monthly,quarterly or yearly. Time series can be used by management to make current decisions &
plans based on long-term forecasting.
Components of a Time-series:
Secular trend: The smooth long-term direction of a time series.
Cyclical variation: The rise & fall of a time series over periods longer than oneyear.
Seasonal variation: Patterns of change in a time series within a year.
Irregular variation: Episodic & residual fluctuations.
Linear Trend:
The long-term trend of many business series, such as sales, exports & production oftenapproximates a straight line. The equation to describe this growth is:
= a+ bt
Where:
is the projected value of the y variable for a selected value of t.
a is the Y-intercept. It is the estimated value of y when t = 0.
b is the slope of the line or the average change in for each increase of one unit in t.
t is any value of time that is selected.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
9/34
Growth Rate: It indicates that during the period of 200X to 200Y dependent variableincreases or decreases at an average of growth rate per year.
Acceleration Rate:It indicates that in the years to come growth rate will be increasedor decreased at an average rate of acceleration rate per year of the previous years growthrate.
Multiple Regression & Correlation Analysis:
Multiple Regressions: The general descriptive form of a multiple regression equation
isy = a + b1X1+ b2X2++b3X3+. + bkXk
where a is the Y-intercept when all Xs are zero, b refers to the sample regression co-efficient & X refers to the value of the various independent variables.
Multiple Standard Error of Estimate: It is similar to the standard deviation. It ismeasured in the same units as the dependent variables. It is based on squared deviations
from the regression equation.
Coefficient of multiple determinations: The coefficient of multiple determinationreports the percent of the variation in the dependent variable explained by the set ofindependents variable. It may range from 1 to 0.
It is also based on squared deviations from the regression equation. It is found by thefollowing equation:
=
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
10/34
ANOVA Table: An ANOVA table summarizes the multiple regression analysis. Itreports the total amount of the variation in the dependent variables & divides thisvariation into that explained by the set of independent variables & that not explained. Italso reports the degrees of freedom associated with the independent variables, the error
variation & total variation.
Correlation Matrix: A correlation matrix shows all possible simple correlationcoefficients between pairs of variables.
Global Test: A global test is used to investigate whether any of the independentvariables have significant regression coefficients. The test statistics is the F distribution.
Individual Regression Coefficient: The test for individual variables determineswhich independent variables have nonzero regression coefficients. The variables thathave zero regression coefficients are usually dropped from the analysis. The test statisticsis the t distribution with n - (k + 1) degrees of freedom.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
11/34
COM PAN Y PR OFI LE
Established as the first private sector bank fully owned by Bangladeshi entrepreneurs,NBL has been flourishing as the largest private sector Bank with the passage of time afterfacing many stress and strain. To keep pace with time and in harmony with national andinternational economic activities and for rendering all modern services, NBL, as afinancial institution, automated all its branches with computer networks in accordancewith the competitive commercial demand of time. Moreover, considering its forth-
coming future, the infrastructure of the Bank has been rearranging. The expectation of allclass businessmen, entrepreneurs and general public is much more to NBL. At present wehave 145 branches under our branch network
National Bank Limited was born as the first hundred percent Bangladeshi owned Bank inthe private sector. From the very inception, it was the firm determination of NationalBank Limited to play a vital role in the national economy. We are determined to bring
back the long forgotten taste of banking services and flavors. We want to serve each onepromptly and with a sense of dedication and dignity.
At present, NBL has been carrying on business through its 130 branches and 15 SME /Agri Branches (total 145 service locations) spread all over the country. Since the very
beginning, the bank has exerted much emphasis on overseas operations and handled asizable quantum of home bound foreign remittance. It has drawing arrangements with415 correspondents in 75 countries of the world, as well as with 37 overseas ExchangeCompanies located in 13 countries. NBL was the first domestic bank to establish agencyarrangements with the world famous Western Union in order to facilitate quick and saferemittance of the valuable foreign exchanges earned by the expatriate Bangladeshinationals. This has meant that the expatriates can remit their hard-earned money to thecountry with much ease, confidence, safety and speed
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
12/34
NATIONAL BANK- MULTIPLE LINEAR REGRESSIONANALYSIS AND INTERPRETATION
In our report, we have been told to draw a Multiple linear regression between following
variables where,The only dependent variable - Share priceThe 4 independent variables.-
1. Net income2. Return on equity3. Price earnings ratio4. Dividend per share
NATIONAL BANK-DATA SUMMARY
We were required to collect last 10 years data. That is given below-
YEAR SHAREPRICE
NET PROFIT DPS ROE P/E
2000 431.5 11.34 30.0 5.34 37.562001 615.25 17.43 40.0 4.12 67.232002 650.0 16.25 50.0 4.16 72.562003 1261.0 22.57 70.0 5.55 105.562004 3200.0 25.0 70.0 12.27 145.592005 3000.0 26.0 70.0 10.43 192.572006 3099.25 24.65 70.0 23.14 242.132007 7491.25 26.29 70.0 40.31 358.022008 7789.25 26.06 75.0 32.5 438.672009 12051.5 27.34 85.0 36.09 594.48
Data Analysis:
Now we are prepared to use SPSS to compute all the statistics needed for the analysis.The Regression equation intercept is labeled as constant in the SPSS:
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
13/34
Coefficientsa
Model
Unstandardized
Coefficients
Standardiz
ed
Coefficient
s
t Sig.
95% Confidence
Interval for B Correlations
Collinearity
Statistics
B Std. Error Beta
Lower
Bound
Upper
Bound
Zero-
order Partial Part
Toleranc
e VIF
1 (Constant)-404.174 1412.711 -.286 .786 -4035.664
3227.31
5
ROE 3.834 199.776 .005 .019 .985 -509.707 517.375 .717 .009 .001 .067 14.837
DPS -9.230 66.177 -.041 -.139 .895 -179.343 160.883 .743 -.062 -.010 .061 16.500
PE 15.083 54.317 .055 .278 .792 -124.542 154.709 .912 .123 .020 .130 7.720
N.P 20.391 4.703 .963 4.335 .007 8.300 32.481 .986 .889 .312 .105 9.558
a. Dependent Variable: S.Price
In this case the estimated regression equation is =-404.174+3.834X1-9.230 X2+15.083 X3+20.391X4Here, r =0.987 This is the multiple regressions and it indicates a positive relation betweenvariables. It is close to 1 so we can say, there is strong positive relationship.Here, b1=3.834 it means that if the independent variable (Net income) increases by 1 takathen the dependent variable will increase by 3.834 taka. We can interpret other b by the
same.We can now estimate the share price in next year as shown before.The regression coefficient and their algebraic signs, also provide information about theirindividual relationship with the next year share price. The regression coefficient for Netincome is .005659. It is positive and shows a positive relationship between share priceand net income. It is logical. Cause, net income and share price tend to move in samedirection.
MULTIPLE STANDARD ERROR OF ESTIMATE
in the National Bank`s case we get the standard error of estimation is an amount equal to307.3944.we interpret this result as, It is the typical error when we use the equation to
predict the cost.First, the units are same as the dependent variable that is taka.Second, we expect the residuals to be approximately normally distributed. So, about 68%of the residuals will be within 307.3944and about 95% within 2(307.3944) =614.7888.here in National Bank`s case, the values are very close to this guideline.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
14/34
THE ANOVA TABLEANOVA
b
Model Sum of Squares df Mean Square F Sig.
1 Regression 1.332E8 4 3.330E7 47.163 .000a
Residual 3530134.188 5 706026.838
Total 1.367E8 9
a. Predictors: (Constant), N.P, ROE, PE, DPS
b. Dependent Variable: S.Price
Here, total variation is divided into 2 components:1. variation in the dependent variable by the regression model( the independent
variables)2. The residual of error variation. That is the random error due to sampling.
There are 3 categories identified in the 1st or source column in the Anova table:
i. Regressionii. Residualiii.Total
The 2nd column is labeled dfin Anova table. It is the degree of freedom. Here totaldegrees of freedom are n-(k+1) = 10-(4+1) =5The heading SS in the 3rd column of Anova table is the sum of squares or the variation.total variation= SStotal=1.367E8Residual error= SSE= 3530134.188Regression variation= 1.332E8
The 4th column heading MS or mean square. is obtained by dividing the SS quantity bythe matching df. Thus the MSR , the mean square regression is equal to SSR/K.Similarly, MSE , the mean square error is SSE/ n-(k+1). (3530134.188/5)
4.76
Sig. level:0.05
Calculate
value:47.163
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
15/34
COEFFICIENT OF DETERMINATION
r2= SSR total/SS total =.974We interpret this value as, independent variables explain or account for, 97.4% of the
variation in share price.
ADJUSTED COEFFICIENT OF DETERMINATION
The number of independent variable in a multiple linear regression makes the coefficientof determination larger. Each new variable causes the predictions to be more accurate.That in turn makes SSE smaller, and SSR larger.To balance the effect of the number of independent variable has on coefficient ofdetermination the statistical software or here SPSS used an adjusted coefficient ofdetermination.Here, the value is = .954
INFERENCES IN MULTIPLE LINEAR REGRESSIONS
Multiple regression analysis is not only a way to describe the relationship between adependent variable and several independent variables. The least square method also hasthe ability to draw inferences or generalization about the relationship for an entire
population.the model of relationship-=+ 1X1+2X2++kXkhere, the coefficients are reported as Greek letter. - ,measures the strength of influence ofindependent variable on dependent variable. =198.7785+.005X1-.041 X2+.055 X3+.963 X4
in our equation, 1= .0052= -.0413= .0554= .963
4 is the largest. So, we can say that return on equity has the highest influence on shareprice.
Model Summaryb
Model R
R
Square
Adjusted R
Square
Std. Error of the
Estimate
Change Statistics
Durbin-
Watson
R Square
Change
F
Change df1 df2
Sig. F
Change
1 .987a
.974 .954 840.25403 .974 47.163 4 5 .000 2.660
a. Predictors: (Constant), N.P, ROE, PE, DPS
b. Dependent Variable: S.Price
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
16/34
TESTING THE MULTIPLE REGRESSION MODEL
The critical value if F is found in Appendix b.4.using the table for the .05 significancelevel, move horizontally to 4 degrees of freedom in numerator and down to 5 degrees ofdenominator we found the critical value= 5.19 . if computed value exceeds this, the nullhypothesis will be rejected.
here, we found f value- 1.2387.so the decision is not to reject null hypothesis.
EVALUATING INDIVIDUAL REGRESSION COEFFECIENTS
The critical value for a t is in appendix b.2. For a 2 tailed test with 5 degrees of freedomusing .05 significance level, null hypothesis is rejected if t is less than 2.571 or greaterthan 2.571.Here t-stat for all independent variable is not in rejection area except dividend per share.
Thus 4 couldn`t be 0. We can say, none of the independent variables are significantpredictor for share price except dps. The dividend per share is an important predictor forshare price. We can drop others and rerun the analysis with dividend per share asindependent variable.Here t=.547
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
17/34
COM PAN Y PR OFI LE
AB Bank Limited, the first private sector bank was incorporated in Bangladesh on 31st December 1981
as Arab Bangladesh Bank Limited and started its operation with effect from April 12, 1982.
AB Bank is known as one of leading bank of the country since its commencement 29 years ago. It
continues to remain updated with the latest products and services, considering consumer and client
perspectives. AB Bank has thus been able to keep their consumers and clients trust while upholding
their reliability, across time.
In spite of adverse market conditions, AB Bank Limited which turned 28 this year, concluded the 2008
financial year with good results. The Banks consolidated profit after taxes amounted to Taka 230 cr
which is 21% higher than that of 2007. The asset base of AB grew by 32% from 2007 to stand at over Tk8,400 cr as at the end of 2008.
AB Bank believes in modernization. The bank took a conscious decision to rejuvenate its past identity
an identity that the bank carried as Arab Bangladesh Bank Limited for twenty five long years. As a result
of this decision, the bank chose to rename itself as AB Bank Limited and the Bangladesh Bank put its
affirmative stamp on November 14, 2007.
AB Bank commits to nation to take a lead in the Banking sector through not only its strong financial
position, but also through innovation of products and services. It also ensures creating higher value for
its respected customers and shareholders. The bank has focused to bring services at the doorstep of its
customers, and to bring millions into banking channels those who are outside the mainstream bankingarena. Innovative products and services were introduced in the field of Small and Medium Enterprise
(SME) credit, Womens Entrepreneur, Consumer Loans, Debit and Credit Cards (Local & International),
ATMs, Internet and SMS Banking, Remittance Services, Treasury Products and Services, Structured
Finance for Corporate, strengthening and expanding its Islamic Banking activities, Investment Banking,
specialized products and services for NRBs, Priority Banking, and Customer Care. The Bank has
successfully completed its automation project in mid 2008. It envisages enabling customers to get
banking services within the comfort of their homes and offices.
AB is recognized as the peoples choice, catering to the satisfaction of its cliental. Their satisfaction is
ABs success.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
18/34
AB BANK-DATA SUMMARY
We collected 10 years data below from 2000 to 2009 of AB Bank Ltd.
AB Bank Ltd.
YEAR SHAREPRICE
NET PROFIT DPS ROE P/E EPS
2000 109.02 158.86 18.0 17.87 4.38 38.752001 213.35 263.28 25.0 24.45 2.79 64.222002 254.58 23.69 15.0 2.07 53.0 5.782003 211.66 17.12 5.0 1.53 53.89 3.632004 257.25 90.07 5.0 7.24 20.95 18.192005 315.14 162.45 10.0 10.64 11.68 31.262006 566.91 532.19 30.0 20.61 9.59 93.082007 1709.43 1903.49 200.0 42.19 10.0 85.37
2008 1934.14 2300.62 15.0 34.2 7.97 103.182009 831.85 3417.18 25.0 33.88 6.24 133.26
Data Analysis:
Descriptive Statistics
Mean Std. Deviation N
S.PRICE 6.4033E2 659.01034 10
NP 8.8690E2 1208.33008 10
DPS 34.8000 58.65492 10
ROE 19.4680 14.22683 10
PE 18.0490 19.29936 10
EPS 57.6720 44.81578 10
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
19/34
Correlations
S.PRICE NP DPS ROE PE EPS
Pearson Correlation S.PRICE 1.000 .743 .582 .791 -.327 .657
NP .743 1.000 .345 .807 -.424 .868
DPS .582 .345 1.000 .633 -.224 .316
ROE .791 .807 .633 1.000 -.727 .885
PE -.327 -.424 -.224 -.727 1.000 -.695
EPS .657 .868 .316 .885 -.695 1.000
Sig. (1-tailed) S.PRICE . .007 .039 .003 .178 .020
NP .007 . .165 .002 .111 .001
DPS .039 .165 . .025 .267 .186
ROE .003 .002 .025 . .009 .000
PE .178 .111 .267 .009 . .013
EPS .020 .001 .186 .000 .013 .
N S.PRICE 10 10 10 10 10 10
NP 10 10 10 10 10 10
DPS 10 10 10 10 10 10
ROE 10 10 10 10 10 10
PE 10 10 10 10 10 10
EPS 10 10 10 10 10 10
Model Summaryb
Model R
R
Square
Adjusted R
Square
Std. Error of the
Estimate
Change Statistics
Durbin-
Watson
R Square
Change
F
Change df1 df2
Sig. F
Change
1 .879a
.772 .488 471.73463 .772 2.713 5 4 .178 1.616
a. Predictors: (Constant), EPS, DPS, PE, NP, ROE
b. Dependent Variable: S.PRICE
Our findings from regression analysis:
R=.879; this suggests that there is very strong relationship among dependent variable that is share price
and independent variables such as net income, DPS, EPS, ROE and P/E ratio.
R2=.772; this indicates 77.2% of dependent variables: share price can be explained by independent
variables: net income, DPS, EPS, ROE, P/E ratio.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
20/34
Coefficientsa
Model
Unstandardized
Coefficients
Standardiz
ed
Coefficient
s
t Sig.
95% Confidence
Interval for B Correlations
Collinearity
Statistics
B Std. Error Beta
Lower
Bound
Upper
Bound
Zero-
order Partial Part
Tolera
nce VIF
1 (Constant) -
739.500887.853 -.833 .452
-
3204.5741725.574
NP .071 .356 .130 .199 .852 -.917 1.058 .743 .099 .047 .134 7.474
DPS -2.219 5.670 -.198 -.391 .715 -17.960 13.522 .582 -.192 -.093 .224 4.473
ROE 71.526 54.533 1.544 1.312 .260 -79.882 222.934 .791 .548 .313 .041 24.344
PE 18.319 18.094 .536 1.012 .369 -31.918 68.555 -.327 .452 .242 .203 4.932
EPS -5.700 11.713 -.388 -.487 .652 -38.220 26.821 .657 -.236 -.116 .090 11.144
a. Dependent Variable: S.PRICE
CoefficientsCo-efficient and constant of regression:
i. Regression equationY = -739.50+ .071x1-2.219x2+71.526X3+18.319X4-5.70X5
ii. Constant a= -739.50 indicates that share price is equal to -739.50 tk irrespective ofthe independent variables.
iii. b1=.071 suggests that for each million tk increase in net income share price isincreased by tk .071 m.
iv. b2=-2.219 suggests that for each additional % increase in DPS share price isdecreased by 2.219%.
v. b3=71.526 suggests that for each percent increase in ROE share price is increasedby 71.526%.
vi. b4=18.319 suggests that for each time increase in P/E ratio share price is increasedby 18.319 times.
vii. b5=-5.70 suggests that for each additional % increase in EPS share price isdecreased by 5.70%
1=.130, 2=-0.198, 3=1.544, 4=0.536 and 5=-.388 Beta measures strength of influence of the independent
variable over the dependent variable. Amongthe Betas 3 is the highest so that we can say upon the share
price influence ROE is the strongest.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
21/34
ANOVAb
Model Sum of Squares df Mean Square F Sig.
1 Regression 3018517.397 5 603703.479 2.713 .178a
Residual 890134.226 4 222533.556
Total 3908651.623 9
a. Predictors: (Constant), EPS, DPS, PE, NP, ROE
b. Dependent Variable: S.PRICE
With df=5 and df=4 table value of F=6.26 and calculated value of F=2.713 where F
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
22/34
COM PAN Y PR OFI LE
The Company started its operations as Pfizer (Bangladesh) Limited in 1972. For the nexttwo decades it continued as a highly successful subsidiary of Pfizer Corporation.However, by the late 1990s the focus of Pfizer had shifted from formulations to research.In accordance with this transformation, Pfizer divested its interests in many countries,including Bangladesh. Specifically, in 1993 Pfizer transferred the ownership of its
Bangladesh operations to local shareholders, and the name of the company was changedto Renata Limited.
In a gesture of corporate charity, Pfizer donated shares so that, along with a partialpayment from the SAJIDA Foundation, 51% ownership of Renata Limited would be heldby the Foundation. Today SAJIDAs microfinance and micro-insurance programssupport over 107,120 members and their families; thus far cumulative loan disbursementtotals BDT 5,750 million. Currently, SAJIDAs health program covers over 1 million
beneficiaries by delivering services through two 70 bed hospitals, panel doctors inSAJIDAs micro finance branches, and mobile health teams. To date, the SAJIDAFoundation holds the majority ownership in Renata Limited.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
23/34
RENATA LIMITED-DATA SUMMARYWe collected 10 years data below from 2000 to 2009 ofRenata Pharmaceuticals
Renata Limited
Year Market SharePrice
ROE DPS P/E NP
2000 450.5 12.34 25.0 4.34 35.562001 615.25 17.43 40.0 4.12 67.23
2002 650.0 16.25 50.0 4.16 72.56
2003 1261.0 22.57 70.0 5.55 105.56
2004 3200.0 25.0 70.0 12.27 145.59
2005 3000.0 26.0 70.0 10.43 192.57
2006 3099.25 23.65 70.0 23.14 242.13
2007 6491.25 26.29 70.0 40.31 358.02
2008 7789.25 26.06 75.0 32.5 438.67
2009 12051.5 25.34 80.0 35.09 590.48
Where market price is dependent variable and ROE, DPS, P/E, and NP are independentvariable.Data Analysis:
Model Summaryb
Model R
R
Square
Adjusted R
Square
Std. Error of the
Estimate
Change Statistics
Durbin-
Watson
R Square
Change
F
Change df1 df2
Sig. F
Change
1 .990a
.980 .964 724.80515 .980 60.819 4 5 .000 2.493
a. Predictors: (Constant), NP, ROE, PE, DPS
b. Dependent Variable: S.Price
INTERPRETATION OF THE COEFFICIENT OF MULTIPLE
DETERMINATIONS (R2)
The model summary shows some important indicators of the explaining power of themodel. The R-square value shows the percent of variation in the dependent variable is
explained by the set of independent variables. In this case, r-square value of .980 or
98.0% means that the independent variables (return on equity, dividend per share, price
earnings ratio, and net income) explain 98.0 percent of change in share price.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
24/34
INTERPRETATION OF ADJUSTED COEFFICIENT OF
DETERMINATION (R2
adj):
On the other hand, the adjusted r-square value shows the percent of variation in the
dependent variable is explained by the statistically significant independent variables. So
in this case, an adjusted r-square value of .964 or 96.4% means that the statisticallysignificant independent variables explain 96.4 percent of the variation in labor
productivity and it also indicates the model has the strong predictive power. If we
compare R-square (.980) to the adjusted R-square (.964), the difference in this case is
small.
ANALYSIS OF VARIANCE (ANOVA)
ANOVAb
Model Sum of Squares df Mean Square F Sig.
1 Regression 1.278E8 4 3.195E7 60.819 .000a
Residual 2626712.517 5 525342.503
Total 1.304E8 9
a. Predictors: (Constant), NP, ROE, PE, DPS
b. Dependent Variable: S.Price
Now we are testing the ability of the independent variables X1, X2Xk to explain thebehavior of the dependent variable y. this test is called global test. It mainly investigateswhether it is possible all the independent variables have zero regression coefficients. Wewill test whether the independent variable (DPS, net income, P/E ratio) effectivelyestimates the market price of share. In testing hypothesis, we first state the nullhypothesis and the alternate hypothesis. We have 4 independent variables such as b1, b2,
b3, b4 are simple regression coefficients. The corresponding coefficients in the populationare given in the symbol 1, 2, 3, 4.
The null hypothesis is
Ho: 1= 2= 3= 4 = 0
The alternate hypothesis is
H1: Not all the s are 0
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
25/34
If the null hypothesis is true, it implies the regression coefficients is 0 and logically are ofno use in estimating the dependent variable. We have to search some for otherindependent variable to predict share price. To test null hypothesis that the multipleregression are all 0, we have to find out a critical value. From appendix B.4 in our test
book and we have used 0.05 significant level. Here the degree of freedom in numerator is
4 because there are 4 independent variables and the degree of denominator is 5 foundedby {n-(k+1)} =10-(4+1) =5.
So the critical value is 5.41. The region where Ho is not rejected and the region where Hois rejected are shown in the following diagram.
Continuing with the global test, the decision tool is not to reject the null hypothesis. Thecomputed value of f is less than or equal 4.76. If the computed value is more than 4.76then we reject the Ho.
The value of F is found from the following equation: F =
= 60.819
The computed value of F is 60.81 which is in the rejection region. The null hypothesis
that the multiple regression coefficients are 0 is therefore rejected. This means that sumof the independent variables have the ability to explain the variation in the dependentvariable.
4.76
Regionwhere
Ho is not
rejected
Region of
rejection (0.05
level)
SSR/k
SSE/[m-(k+1)]
Calculated
value: 60.819
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
26/34
Evaluating individual regression coefficient:
Our next step is to test the independent variables individually to determine whichregression coefficients may be 0 and which are not. If a could be equal to 0, it indicatesthat this particular independent variable is of no value in explain any variation in thedependent value. If there are coefficients for which Ho cant be rejected. We may want to
eliminate coefficient from regression equation.
We will now conduct four separate test of hypothesis:
For ROE For DPS For P/E ratioFor NP
Ho: 1 = 0 2 = 0 3 = 04 = 0
H1 1 0 2 0 3 04 0
We will test the hypothesis at 0.05 significant level.
The alternate hypothesis stated indicates that the test is two tail. The test statistic follows tdistribution with n-(k+1) degrees of freedom. The number of sample observation is n=10.The number of independent variables are k=4. Thus there are 5 degrees of freedom.
The critical value in Appendix B.2 for a two tailed test with degrees of freedom using
0.05 significant level Ho is rejected if t is less than -2.571 or more than 2.571.Coefficients
a
Model
Unstandardized
Coefficients
Standardized
Coefficients
t Sig.
95% Confidence
Interval for B Correlations
Collinearity
Statistics
B Std. Error Beta
Lower
Bound
Upper
Bound
Zero-
order Partial Part Tolerance VIF
1 (Constant) -610.976 1387.980 -.440 .678 -4178.892 2956.941
ROE 70.914 175.092 .092 .405 .702 -379.175 521.003 .663 .178 .026 .077 12.9
DPS -29.198 49.956 -.136 -.584 .584 -157.615 99.219 .688 -.253 -.037 .075 13.3
PE -40.138 46.542 -.151 -.862 .428 -159.778 79.503 .880 -.360 -.055 .132 7.5
NP 24.041 3.774 1.158 6.370 .001 14.340 33.743 .988 .944 .404 .122 8.2
a. Dependent Variable: S.Price
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
27/34
The regression model is Y= -610.976 + 70.914X1 -29.198X2 -40.138 X3 +24.041 X4
The intercept value of -610.976 indicates the regression intersect the Y-axis at -610.976when X1, X2, X3, and X4 are 0.
b1 of 70.914indicates that for each increase in 1% ROE, share price will increase by70.914Tk.
b2 of -29.198 indicates that for each increase in 1tk. DPS, share price will decrease by -29.198Tk.
b3 of -40.138 indicates that for each increase in 1tk. Price Earnings ratio, share price willdecrease by 40.138 Tk.
b4 of 24.041 indicates that for each increase in 1 million tk., Net Profit share price will
increase by 24.041Tk.
As b1 is highest, it means that influence of Net Profit is fluctuating over increasingmarket share price.
The sample distribution of coefficient follows the t distribution n-(k+1). Hence we areable to test independent variables individually to determine whether the regressioncoefficients differ from 0. The computed t ratio is 0.405 for ROE, -.584 for DPS, 0.862
for P/E ratio and 4.335 for Net Profit. The regression coefficient for Net Profit is not 0because it is right to the 2.571 and ROE, P/E ratio and DPS fall into the region within -6.370. So independent variable P/E ratio, DPS and ROE have no effect over dependentvariable. It can be dropped from the analysis. So we can conclude that only Net Profitmakes an impact over changing market share price.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
28/34
COM PAN Y PR OFI LE
The company was incorporated in 1976 and commenced operations in 1980 with the
manufacturing and marketing of products of Bayer AG, Germany and Upjohn Inc., USA under
licensing arrangements. In 1983, the company started manufacturing its own formulations and
it launched export operation in 1992. In 2005 Beximco Infusions Ltd, the company that
produces intravenous fluids, was amalgamated with the parent company. In the same year it
completed the state-of-the-art oral solid dosage plant in compliance with the US FDA and UK
MHRA standards, which has been approved by major global regulatory bodies. Today Beximco
Pharma is the largest exporter of pharmaceuticals in the country and the only company to win
National Export Trophy (Gold), the highest national accolade for export, for record three times.The company is the largest producer of Metered Dose Inhalers (MDIs) in the country, and the
first to produce CFC free inhalers. BPL is also the first company to produce anti-retroviral drugs
(ARVs) locally. As a public limited company, its shares are actively traded in Dhaka Stock
Exchange and Chittagong Stock Exchange, and Beximco Pharma has the unique distinction of
being the only company in the country listed on AIM of London Stock Exchange.
Beximco Pharmaceuticals Ltd (BPL) is a leading manufacturer of pharmaceutical formulations
and Active Pharmaceutical Ingredients (APIs) in Bangladesh. The company is the largest
exporter of pharmaceuticals in the country and its state-of-the-art manufacturing facilities are
certified by global regulatory bodies of Australia, Gulf nations, Brazil, among others. The
company is consistently building upon its portfolio and currently producing more than 400
products in different dosage forms covering broader therapeutic categories which include
antibiotics, antihypertensives, antidiabetics, antireretrovirals, anti asthma inhalers etc, among
many others.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
29/34
BEXIMCO PHARMA-DATA SUMMARY
We collected 10 years data below from 2000 to 2009 of Beximco Pharmaceuticals
Ltd.
Beximco Pharmaceuticals Ltd.
YEAR SHAREPRICE
NETPROFIT
DPS ROE P/E EPS
2000 49.75 398.3 20.0 10.58 9.4 7.122001 54.88 401.78 15.0 9.64 8.62 5.742002 42.83 341.68 15.0 7.7 8.57 4.882003 35.03 207.14 20.0 4.46 13.42 2.962004 57.1 329.38 30.0 6.81 19.55 4.712005 78.25 489.26 15.0 7.17 9.09 6.362006 52.41 470.66 15.0 5.92 13.06 4.112007 54.85 353.07 15.0 4.28 21.04 2.82008 104.48 545.34 30.0 5.22 46.45 3.61
2009 157.0 624.74 15.0 5.74 37.72 4.13
Data Analysis:
Descriptive Statistics
Mean Std. Deviation N
S.PRICE 68.6580 36.68643 10
NP 4.1614E2 120.08351 10
DPS 19.0000 6.14636 10
ROE 6.7520 2.09492 10
PE 18.6920 13.25298 10
EPS 4.6420 1.42170 10
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
30/34
Correlations
S.PRICE NP DPS ROE PE EPS
Pearson Correlation S.PRICE 1.000 .863 .050 -.221 .774 -.094
NP .863 1.000 -.075 .011 .593 .157
DPS .050 -.075 1.000 -.125 .486 -.133
ROE -.221 .011 -.125 1.000 -.516 .916
PE .774 .593 .486 -.516 1.000 -.494
EPS -.094 .157 -.133 .916 -.494 1.000
Sig. (1-tailed) S.PRICE . .001 .446 .270 .004 .398
NP .001 . .419 .488 .035 .333
DPS .446 .419 . .366 .077 .357
ROE .270 .488 .366 . .063 .000
PE .004 .035 .077 .063 . .073
EPS .398 .333 .357 .000 .073 .
N S.PRICE 10 10 10 10 10 10
NP 10 10 10 10 10 10
DPS 10 10 10 10 10 10
ROE 10 10 10 10 10 10
PE 10 10 10 10 10 10
EPS 10 10 10 10 10 10
Model Summaryb
Model R
R
Square
Adjusted R
Square
Std. Error of the
Estimate
Change Statistics
Durbin-
Watson
R Square
Change
F
Change df1 df2
Sig. F
Change
1 .954a
.910 .798 16.47965 .910 8.120 5 4 .032 1.678
a. Predictors: (Constant), EPS, DPS, NP, ROE, PE
b. Dependent Variable: S.PRICE
Our findings from regression analysis:
R=.954; this suggests that there is very strong relationship among dependent variable that is share price
and independent variables such as net income, DPS, EPS, ROE and P/E ratio.
R2=.910; this indicates 91% of dependent variables: share price can be explained by independent variables:
net income, DPS, EPS, ROE, P/E ratio.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
31/34
Coefficientsa
Model
Unstandardized
Coefficients
Standardized
Coefficients
t Sig.
95% Confidence
Interval for B Correlations
Collinearity
Statistics
B
Std.
Error Beta
Lower
Bound
Upper
Bound
Zero-
order Partial Part Tolerance VIF
1 (Constant) 10.597 37.977 .279 .794 -94.845 116.039
NP .007 .134 .024 .055 .959 -.363 .378 .863 .028 .008 .117 8.517
DPS-2.749 1.779 -.461
-
1.546.197 -7.687 2.189 .050 -.611
-
.231.253 3.960
ROE-6.389 7.251 -.365 -.881 .428 -26.521 13.743 -.221 -.403
-
.132.131 7.647
PE 3.228 1.514 1.166 2.132 .100 -.975 7.431 .774 .729 .319 .075 13.339
EPS 19.392 14.799 .751 1.310 .260 -21.697 60.481 -.094 .548 .196 .068 14.670
a. Dependent Variable:
S.PRICE
CoefficientsCo-efficient and constant of regression:
i. Regression equation
Y= 10.597+ .007x1-2.749x2-6.389X3+3.228X4+19.392X5
ii. Constant a= 10.597indicates that share price is equal to 10.597 tk irrespective of the
independent variables.
iii. b1=.007 suggests that for each million tk increase in net income share price is
increased by tk .007 m.
iv. b2=-2.749 suggests that for each additional % increase in DPS share price is
decreased by 2.749%.
v. b3=-6.389 suggests that for each % increase in ROE share price is decreased by
6.389%.
vi. b4=3.228 suggests that for each time increase in P/E ratio share price is increased
by 3.228 times.vii. b5=19.392 suggests that for each additional % increase in EPS share price is
increased by 19.392%
1=.024, 2=-0.461, 3=-.365, 4=1.166 and 5=.756 Beta measures strength of influence of the independent
variable over the dependent variable. Among the Betas 4 is the highest so that we can say upon the share
price influence of P/E ratio is the strongest.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
32/34
ANOVAb
Model Sum of Squares df Mean Square F Sig.
1 Regression 11026.735 5 2205.347 8.120 .032a
Residual 1086.315 4 271.579
Total 12113.051 9
a. Predictors: (Constant), EPS, DPS, NP, ROE, PE
b. Dependent Variable: S.PRICE
With df=5 and df=4 table value of F=6.26 and calculated value of F=8.120 where F>F table value means
all regression co-efficient are not zero that is to say for Beximo Pharmaceuticals share price some of the
independent variable do have the ability to explain the variation in the dependent variable.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
33/34
CON CLU S I ON
The aim of the report was to establish and define the association between the share prices of a
company and the performance indicators.
Throughout the analysis of the report it was possible to successfully establish such a relation
between them and to define them to significant precision.
Although the analysis is based on only the past records it, nevertheless, would help us to
predict the future trend of share prices in response to the performance indicators of the
particular companies.
The analysis is also a helpful in understanding of the effectiveness of the company performance
on its share prices. It not only relates to the only four companies we have dealt with, but the
overall capital market.
-
7/29/2019 Applications of Statistics On Banking and Pharmaceutical Companies
34/34
BI BLI OGR APH Y
1. Text Books
i) Statistical Techniques in Business & Economics by Douglas A. Lind,William G. Marchal, Samuel A. Wathen.
ii) Principles of Statistics
2. Websites
i) National Bank Ltd (www.nblbd.com)ii) AB Bank Ltd. (www.abbank.com.bd)iii)Renata Pharmaceuticals (www.renata.com)iv)Beximco Pharmaceuticals Ltd. (www.beximco.com)